4.6 Review

Recent advances in aerosol devices for the delivery of inhaled medications

期刊

EXPERT OPINION ON DRUG DELIVERY
卷 17, 期 2, 页码 133-144

出版社

TAYLOR & FRANCIS LTD
DOI: 10.1080/17425247.2020.1712356

关键词

Aerosols; dry powder inhalers; inhaled drugs; metered-dose inhalers; nebulizers

资金

  1. Adamed
  2. TEVA
  3. Hasco Lek
  4. Lek-AM
  5. GlaxoSmithKline

向作者/读者索取更多资源

Introduction: Aerosolized medications are commonly prescribed for the treatment of patients with pulmonary diseases, and there has been an increased interest in the development of aerosol delivery devices over the years. Technical innovations have advanced device design, novel features such as breath actuation, dose tracking, portability, and feedback mechanism during treatment that improved the performance of aerosol devices, and effectiveness of inhalation therapy. Areas covered: The purpose of this paper is to review recent advances in aerosol devices for delivery of inhaled medications. Expert opinion: Drug formulations and device designs are rapidly evolving to make more consistent dosing across a broad range of inspiratory efforts, to maximize dose and target specific areas of the diseased lung.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.6
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据